Abstract
This study has identified a single amino acid change in the viral glycoprotein that profoundly affects the ability of lymphocytic choriomeningitis virus (LCMV) to persist in its natural host. Adult immunocompetent mice infected with a variant of the Armstrong strain, spleen isolate clone 13 (svA/svA), harbor virus for several months and exhibit suppressed T cell responses. In contrast, adult mice infected with a reassortant virus (svA/wtA) that contains the L segment of the spleen variant and the S segment of the parental wt Armstrong, make potent LCMV-specific CTL responses and clear the infection within 2-4 wk. These two viruses, spleen variant clone 13 and the reassortant svA/wtA, are identical in their noncoding regions and show no amino acid changes in any of their viral genes except for one substitution in the glycoprotein. The reassortant virus svA/wtA has a phenylalanine at amino acid residue 260 of the glycoprotein, whereas the spleen variant clone 13 has a leucine at this position. This study constitutes one of the first reports defining the genetic basis of viral persistence at the whole animal level, and identifying a single mutation that markedly increases the ability of a virus to persist in its natural host.
MeSH Terms
Amino Acid Sequence
Animals
Base Sequence
Glycoproteins/chemistry
Lymphocytic choriomeningitis virus/genetics,pathogenicity
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Mutation
T-Lymphocytes, Cytotoxic/immunology
Viral Proteins/chemistry
Chemicals
Glycoproteins
Viral Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Matloubian M
Department of Microbiology and Immunology, UCLA School of Medicine 90024.
Somasundaram T
Kolhekar S R
Selvakumar R
Ahmed R
References (19)
19 references, click to expand
-
H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
J Immunol. 1976 Nov;117(5 Pt 1):1495-502
PMID: 794412
-
Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis.
J Virol. 1986 Aug;59(2):363-8
PMID: 2426464
-
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
J Exp Med. 1984 Aug 1;160(2):521-40
PMID: 6332167
-
Ambisense RNA genomes of arenaviruses and phleboviruses.
Adv Virus Res. 1986;31:1-51
PMID: 3019106
-
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins.
J Virol. 1987 Apr;61(4):982-5
PMID: 3546729
-
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus.
Virology. 1987 Mar;157(1):145-55
PMID: 3824905
-
Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.
J Virol. 1987 Jun;61(6):1867-74
PMID: 3494855
-
Immune therapy of a persistent and disseminated viral infection.
J Virol. 1987 Dec;61(12):3920-9
PMID: 3682061
-
Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells.
J Virol. 1987 Dec;61(12):3930-7
PMID: 3500329
-
Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).
Virology. 1988 Jun;164(2):517-22
PMID: 3259346
-
Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection.
J Infect Dis. 1988 Jul;158(1):232-5
PMID: 3392416
-
Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus.
J Virol. 1988 Sep;62(9):3301-8
PMID: 3261347
-
Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
J Exp Med. 1988 Aug 1;168(2):559-70
PMID: 2457647
-
The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase.
Virology. 1989 Apr;169(2):377-84
PMID: 2705303
-
Major histocompatibility complex--dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease.
Eur J Immunol. 1989 Sep;19(9):1657-67
PMID: 2477254
-
The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein.
Virology. 1989 Nov;173(1):1-10
PMID: 2510401
-
Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment.
J Virol. 1985 Sep;55(3):704-9
PMID: 4020963
-
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
Nature. 1986 May 15-21;321(6067):239-43
PMID: 3086743
-
Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing.
Nucleic Acids Res. 1981 Sep 25;9(18):4485-94
PMID: 6170937